marijuana stocks

Cara reports 4Q loss

Cara Therapeutics posts loss of $4.2 million in 4th quarter

SHELTON, Conn. (AP) _ Cara Therapeutics Inc. (CARA) on Thursday reported a fourth-quarter loss of $4.2 million, after reporting a profit in the same period a year earlier.

The Shelton, Connecticut-based company said it had a loss of 18 cents per share.

The biotechnology company posted revenue of $914,000 in the period.

For the year, the company reported that its loss widened to $17.7 million, or 85 cents per share. Revenue was reported as $3.2 million.

Cara shares have fallen nearly 7 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $9.30, a drop of 45 percent in the last 12 months.

_____

This story was generated by Automated Insights (https://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CARA at https://www.zacks.com/ap/CARA

_____

Keywords: Cara Therapeutics, Earnings Report


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

The Alkaline Water Company Inc. (WTER.V) (WTER) Announces Pricing of Public Offering of Common Stock

The Alkaline Water Company Inc. Announces Pricing of Public Offering of Common…

 AeroGrow International, Inc. (AERO) Reports 3rd Quarter Results

AeroGrow Reports 3rd Quarter Results  AeroGrow International, Inc. (OTCQB: AERO) (“AeroGrow” or…

$MJNA Portfolio Company HempMeds At SOHO Expo

Medical Marijuana, Inc.’s HempMeds Shows Retail-Ready Cannabis Products at SOHO EXPO Industry…

Tetra Bio-Pharma Inc. (TBPMF) Receives Health Canada Phase 3 Clinical Trial Approval

RETRANSMISSION: Tetra Bio-Pharma Receives Health Canada Phase 3 Clinical Trial Approval For…